2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA
Annual Report to Security Holders
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
Christian Nolet Resigns from Jasper Therapeutics Board; Svetlana Lucas Appointed
Reports First Quarter 2026 Financial Results and Provides Corporate Update
Financial Results, Press Release
BEACON & OLE Data Update January 8, 2026
Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
Q1
FY 2025
Q3
Q2
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
S-8 POS